Dr. Sandro Matosevic
Tuesday, April 30, 2024

Genetically engineering a treatment for incurable brain tumors

 

Purdue researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.